Biolife Sciences (Biolife Sciences) Pre-Tax Income : $-2.68 Mil (TTM As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Biolife Sciences's pretax income for the three months ended in May. 2008 was $-0.84 Mil. Its pretax income for the trailing twelve months (TTM) ended in May. 2008 was $-2.68 Mil. Biolife Sciences's pretax margin was -46.83%.

Biolife Sciences Pre-Tax Income Historical Data

The historical data trend for Biolife Sciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Pre-Tax Income Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Pre-Tax Income

-1.51

-0.29

-2.05

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Pre-Tax Income	Get a 7-Day Free Trial										-0.46	-0.36	-1.03	-0.45	-0.84

Competitive Comparison of Biolife Sciences's Pre-Tax Income

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Pre-Tax Income falls into.

Biolife Sciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Biolife Sciences's Pretax Income for the fiscal year that ended in Nov. 2007 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0.039	+	-1.397	+	0	+	0	+	-0.688
	=	-2.05

Biolife Sciences's Pretax Income for the quarter that ended in May. 2008 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0.084	+	-0.292	+	0	+	0	+	-0.634
	=	-0.84

Pre-Tax Income for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.68 Mil.

Biolife Sciences (OTCPK:BLFE) Pre-Tax Income Explanation

Biolife Sciences's Pretax Margin for the quarter that ended in May. 2008 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.842	/	1.798
	=	-46.83%

Biolife Sciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020